Cornerstone Capital Management Holdings LLC. Has $10.22 Million Holdings in Hill-Rom Holdings, Inc. (HRC)

Cornerstone Capital Management Holdings LLC. boosted its position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 44.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 138,105 shares of the medical technology company’s stock after purchasing an additional 42,326 shares during the period. Cornerstone Capital Management Holdings LLC. owned approximately 0.21% of Hill-Rom worth $10,219,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. BlackRock Inc. increased its position in shares of Hill-Rom by 3.1% during the second quarter. BlackRock Inc. now owns 5,226,138 shares of the medical technology company’s stock valued at $416,053,000 after acquiring an additional 159,074 shares during the last quarter. State Street Corp increased its position in shares of Hill-Rom by 2.7% during the second quarter. State Street Corp now owns 1,681,107 shares of the medical technology company’s stock valued at $133,831,000 after acquiring an additional 43,645 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Hill-Rom by 4.3% during the third quarter. Bank of New York Mellon Corp now owns 1,288,471 shares of the medical technology company’s stock valued at $95,348,000 after acquiring an additional 52,863 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of Hill-Rom by 298.1% during the third quarter. Wells Fargo & Company MN now owns 1,133,900 shares of the medical technology company’s stock valued at $83,908,000 after acquiring an additional 849,050 shares during the last quarter. Finally, Koch Industries Inc. acquired a new stake in shares of Hill-Rom during the second quarter valued at about $1,007,000. 82.35% of the stock is currently owned by institutional investors.

Shares of Hill-Rom Holdings, Inc. (NYSE:HRC) traded down $0.25 during mid-day trading on Wednesday, hitting $82.59. 411,300 shares of the company were exchanged, compared to its average volume of 501,742. The company has a quick ratio of 1.34, a current ratio of 1.77 and a debt-to-equity ratio of 1.55. The firm has a market capitalization of $5,452.61, a PE ratio of 21.46, a P/E/G ratio of 1.76 and a beta of 1.19. Hill-Rom Holdings, Inc. has a 52-week low of $54.59 and a 52-week high of $85.25.

Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.05. The firm had revenue of $738.30 million during the quarter, compared to analysts’ expectations of $731.10 million. Hill-Rom had a net margin of 4.87% and a return on equity of 20.27%. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.18 earnings per share. equities analysts forecast that Hill-Rom Holdings, Inc. will post 4.26 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Thursday, December 14th. Hill-Rom’s dividend payout ratio (DPR) is currently 36.18%.

A number of equities research analysts have weighed in on HRC shares. Needham & Company LLC dropped their price target on shares of Hill-Rom from $93.00 to $90.00 and set a “buy” rating for the company in a research report on Monday, November 6th. Zacks Investment Research upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $90.00 price target for the company in a research report on Friday, October 27th. KeyCorp reiterated a “buy” rating and set a $89.00 price target (up from $82.00) on shares of Hill-Rom in a research report on Sunday, November 5th. Barclays lifted their price target on shares of Hill-Rom from $86.00 to $90.00 and gave the company an “overweight” rating in a research report on Monday, November 6th. Finally, ValuEngine cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Saturday, November 4th. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $89.57.

In related news, SVP Andreas G. Frank sold 6,870 shares of Hill-Rom stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares in the company, valued at $1,293,993.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Cornerstone Capital Management Holdings LLC. Has $10.22 Million Holdings in Hill-Rom Holdings, Inc. (HRC)” was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/12/13/cornerstone-capital-management-holdings-llc-has-10-22-million-holdings-in-hill-rom-holdings-inc-hrc.html.

About Hill-Rom

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

What are top analysts saying about Hill-Rom? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hill-Rom and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit